Glynn-Barnhart A, Hill M, Szefler S J
Ira and Jacqueline Neimark Laboratory of Clinical Pharmacology in Pediatrics, Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver.
Drugs. 1988 Jun;35(6):711-26. doi: 10.2165/00003495-198835060-00006.
Theophylline is an important antiasthmatic medication which has bronchodilator properties. With increased understanding of the relationships of serum theophylline concentration and effect, both adverse and beneficial, oral dosage forms were developed to provide consistent serum theophylline concentrations with the benefit of convenient dosage intervals for long term use. Since factors such as concurrent disease states, drug interactions and age have a profound effect on theophylline disposition, relatively sophisticated dosage guidelines have evolved. Theophylline is in fact a model drug for the application of pharmacokinetic principles to the individualization of a treatment regimen. The purpose of this discussion is to review the relationship of serum theophylline concentration and pharmacodynamic effect and the special properties of oral sustained release theophylline formulations, and to provide a practical approach to prescribing theophylline. Guidelines are provided on the use of serum theophylline concentrations to individualize the theophylline dose, with an analysis of available techniques to monitor theophylline.
茶碱是一种重要的抗哮喘药物,具有支气管扩张特性。随着对血清茶碱浓度与疗效(包括不良反应和有益作用)之间关系的深入了解,开发出口服剂型,以便在长期使用时能以方便的给药间隔提供稳定的血清茶碱浓度。由于诸如并发疾病状态、药物相互作用和年龄等因素对茶碱的处置有深远影响,因此已经形成了相对复杂的给药指导原则。实际上,茶碱是将药代动力学原理应用于治疗方案个体化的一种典型药物。本次讨论的目的是回顾血清茶碱浓度与药效学效应之间的关系以及口服缓释茶碱制剂的特殊性质,并提供一种实用的茶碱处方方法。文中给出了利用血清茶碱浓度个体化确定茶碱剂量的指导原则,并分析了监测茶碱的现有技术。